SARS-CoV-2 vaccination in people with HIV
- PMID: 34153265
- PMCID: PMC8213375
- DOI: 10.1016/S2352-3018(21)00128-4
SARS-CoV-2 vaccination in people with HIV
Conflict of interest statement
I am funded by the National Institutes of Health National Institute of Allergy and Infectious Diseases (R01AI158013) supported this work.
Comment on
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.Lancet HIV. 2021 Aug;8(8):e474-e485. doi: 10.1016/S2352-3018(21)00103-X. Epub 2021 Jun 18. Lancet HIV. 2021. PMID: 34153264 Free PMC article. Clinical Trial.
References
-
- van den Berg R, van Hoogstraten I, van Agtmael M. Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions. AIDS Rev. 2009;11:157–164. - PubMed
-
- Kroon FP, van Dissel JT, Labadie J, van Loon AM, van Furth R. Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. Clin Infect Dis. 1995;21:1197–1203. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
